chr7-5491387-G-A
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_024963.6(FBXL18):c.1844C>T(p.Ser615Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000361 in 1,607,442 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024963.6 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXL18 | ENST00000382368.8 | c.1844C>T | p.Ser615Leu | missense_variant | Exon 4 of 5 | 5 | NM_024963.6 | ENSP00000371805.3 | ||
FBXL18 | ENST00000458142.1 | c.1493C>T | p.Ser498Leu | missense_variant | Exon 2 of 3 | 2 | ENSP00000405896.1 | |||
FBXL18 | ENST00000415009.5 | n.1844C>T | non_coding_transcript_exon_variant | Exon 4 of 7 | 2 | ENSP00000415064.1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152242Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000216 AC: 5AN: 231124 AF XY: 0.0000237 show subpopulations
GnomAD4 exome AF: 0.0000357 AC: 52AN: 1455084Hom.: 0 Cov.: 33 AF XY: 0.0000318 AC XY: 23AN XY: 723494 show subpopulations
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152358Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74490 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1844C>T (p.S615L) alteration is located in exon 4 (coding exon 4) of the FBXL18 gene. This alteration results from a C to T substitution at nucleotide position 1844, causing the serine (S) at amino acid position 615 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at